These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6131356)

  • 1. Increased immunoreactive dynorphin and leu-enkephalin in posterior pituitary of obese mice (ob/ob) and super-sensitivity to drugs that act at kappa receptors.
    Ferguson-Segall M; Flynn JJ; Walker J; Margules DL
    Life Sci; 1982 Nov 15-22; 31(20-21):2233-6. PubMed ID: 6131356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
    Morley JE; Levine AS; Gosnell BA; Kneip J; Grace M
    Physiol Behav; 1983 Nov; 31(5):603-6. PubMed ID: 6320237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mu-receptors in the opioid-induced generation of bursting discharges in hippocampal pyramidal cells.
    Gähwiler BH; Maurer R
    Regul Pept; 1981 May; 2(2):91-6. PubMed ID: 6265981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Illes P
    J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential interaction of opiates to multiple "kappa" binding sites in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Life Sci; 1982 Sep 20-27; 31(12-13):1371-5. PubMed ID: 6128659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tritiated ethylketocyclazocine binding in rat brain: differential distribution of binding sites across brain regions.
    Hewlett WA; Akil H; Carlini W; Barchas JD
    Life Sci; 1982 Sep 20-27; 31(12-13):1351-4. PubMed ID: 6128657
    [No Abstract]   [Full Text] [Related]  

  • 19. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.
    Valette A; Tafani M; Porthe G; Pontonnier G; Cros J
    Life Sci; 1983; 33 Suppl 1():523-6. PubMed ID: 6141498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid kappa-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa).
    Deviche P; Moore FL
    Horm Behav; 1987 Sep; 21(3):371-83. PubMed ID: 2822565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.